Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage

Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G551-G561. doi: 10.1152/ajpgi.00175.2018. Epub 2019 Feb 8.

Abstract

Necroptosis, a form of regulated necrosis, has been reported to be involved in numerous pathologies, including sepsis. However, a protective effect of the selective inhibitor of necroptosis, necrostatin-1 (Nec-1), against sepsis remains to be confirmed. Animals (rats and mice) were subjected to cecal ligation and puncture (CLP) to mimic clinical sepsis. Nec-1 or its vehicle (control) was administered 20 min before CLP. Survival time was observed up to 72 h after CLP. Specimens of liver tissue and serum were obtained at 6 h, 12 h, and 18 h. Expression of necroptosis-related proteins [receptor-interacting protein kinase (RIP)1, RIP3, and mixed lineage kinase domain-like (MLKL)] was determined by Western blot analysis. The RIP1/RIP3 interaction and the recruitment of MLKL to RIP3 were also analyzed. Liver function, histopathological changes, serum inflammation cytokines, TUNEL staining, and the expression of apoptosis-related protein, including caspase-3, B-cell lymphoma 2 (Bcl-2), and Bcl-2-associated X (Bax), was determined. As expected, Nec-1 administration reduced the expression of necroptosis-related proteins and the RIP1/RIP3 interaction, indicating inhibited necroptosis. Surprisingly, Nec-1 treatment exacerbated the liver injury and shortened survival time of septic rats with increased TUNEL-positive cells, cleaved caspase-3 protein content, and Bax/Bcl-2 ratio. Collectively, these findings show that Nec-1 administration inhibited the hepatocyte necroptosis pathway but accelerated apoptosis via the apoptotic pathway in CLP-induced sepsis rat. NEW & NOTEWORTHY The present study demonstrated that a chemical inhibitor necrostatin-1 (Nec-1) or receptor-interacting protein kinase(RIP1) knock down targeted at necroptosis inhibition accelerated liver injury of following sepsis. For fundamental research, these results warrant further investigation of the potential link between Nec-1 administration and the cellular apoptosis following sepsis induced liver injury. For applied research, these results suggest the potential harmful effect of Nec-1 on future sepsis treatment.

Keywords: apoptosis; cecal ligation and puncture; liver; necroptosis; necrostatin-1; sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Caspase 3 / metabolism*
  • Disease Models, Animal
  • Imidazoles / pharmacokinetics*
  • Indoles / pharmacokinetics*
  • Liver Diseases* / etiology
  • Liver Diseases* / metabolism
  • Liver Diseases* / pathology
  • Liver Diseases* / physiopathology
  • Mice
  • Necroptosis* / drug effects
  • Necroptosis* / physiology
  • Protein Kinases / metabolism
  • Rats
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism*
  • Receptors, Death Domain / antagonists & inhibitors
  • Sepsis* / complications
  • Sepsis* / metabolism
  • Time Factors

Substances

  • Imidazoles
  • Indoles
  • Receptors, Death Domain
  • necrostatin-1
  • MLKL protein, mouse
  • MLKL protein, rat
  • Protein Kinases
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Caspase 3